MUROMONAB-CD3: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
45.0%
Female
55.0%
Male
Age Information
The average age of patients reporting adverse events with MUROMONAB-CD3 is 30.2 years.
Geographic Distribution
The majority of adverse event reports for MUROMONAB-CD3 originate from US.
Report Summary & Outcomes
114
Total Reports
114
As Primary/Secondary Suspect
28
Deaths Reported
28
Hospitalizations
4
Life-Threatening
Reporting Timeline
First adverse event report: 1996. Most recent report: 201403. View full timeline →